Elsevier Science, Inc.

SHERPA: Unknown

People

  1. Schultz
    Schultz
  2. Solit
    Solit
  3. Berger
    Berger
  4. Hakimi
    Hakimi
  5. Coleman
    Coleman
  6. Al-Ahmadie
    Al-Ahmadie
  7. Iyer
    Iyer
  8. Reznik
    Reznik
  9. Rosenberg
    Rosenberg
  10. Arcila
    Arcila

Groups

  1. Computational Oncology Service (24)
  2. Epidemiology and Biostatistics (24)
  3. GSK Faculty (22)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (17)
  5. Human Oncology and Pathogenesis Program (17)
  6. Surgery (14)
  7. Department of Medicine (13)
  8. Department of Pathology and Laboratory Medicine (13)
  9. Genitourinary Oncology Service (13)
  10. Sloan Kettering Institute Postdocs (13)
Search Within
  1. "Computational Oncology Service"
Formats
  1. Journal Article (12)
  2. Meeting Abstract (11)
  3. Editorial (1)
Groups
  1. Computational Oncology Service (24)
  2. Epidemiology and Biostatistics (24)
  3. GSK Faculty (22)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (17)
  5. Human Oncology and Pathogenesis Program (17)
  6. Surgery (14)

More Groups

People
  1. Nikolaus Schultz (11)
  2. David Solit (9)
  3. Abraham Hakimi (7)
  4. Michael Berger (7)
  5. Jonathan Coleman (6)
  6. Eduard Reznik (5)

More People

Years
  1. 2025 (2)
  2. 2024 (4)
  3. 2023 (2)
  4. 2021 (5)
  5. 2020 (4)
  6. 2019 (1)

More Years

Publications
  1. European Urology (12)
  2. Journal of Molecular Diagnostics (4)
  3. Journal of the American College of Surgeons (3)
  4. Experimental Hematology (2)
  5. Lancet Oncology (1)
  6. The Lancet Haematology (1)

More Publications

Results (24)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Surgeon variability in the adoption of organ preservation for patients with rectal adenocarcinoma treated at a comprehensive cancer center
    Meeting Abstract

    Kim, J. K.; Thompson, H.; Jimenez-Rodriguez, R. M.; Wu, F.; Sanchez-Vega, F.; Nash, G. M.; Weiser, M. R.; Garcia-Aguilar, J.
    Journal of the American College of Surgeons (2021)

    Fulltext@MSK | Save
  • Neutrophil-to-lymphocyte ratio in unclassified renal cell carcinoma is associated with clinical outcome and varies between genomic subgroups
    Meeting Abstract

    Marcon, J.; Di Natale, R. G.; Weng, S.; Ghanaat, M.; Silagy, A. W.; Mano, R.; Blum, K. A.; Attalla, K.; Reznik, E.; Carlo, M. I.; more...
    European Urology (2021)

    Fulltext@MSK | Save
  • The clinicopathologic and molecular landscape of clear cell papillary renal cell carcinoma: Implications in diagnosis and management
    Journal Article

    Weng, S.; DiNatale, R. G.; Silagy, A.; Mano, R.; Attalla, K.; Kashani, M.; Weiss, K.; Benfante, N. E.; Winer, A. G.; Coleman, J. A.; more...
    European Urology (2021)

    Fulltext@MSK | Save
  • Temporal spatial heterogeneity of immune response to SARS-CoV-2 lung infection
    Meeting Abstract

    Desai, N.; Ting, D.; Neyaz, A.; Szabolcs, A.; Shih, A.; Chen, J.; Thapar, V.; Nieman, L.; Solovyov, A.; Mehta, A.; more...
    Journal of Molecular Diagnostics (2020)

    Fulltext@MSK | Save
  • Pan-cancer analysis of CDK12 alterations identifies a subset of prostate cancers with distinct genomic and clinical characteristics
    Journal Article

    Nguyen, B.; Mota, J. M.; Nandakumar, S.; Stopsack, K. H.; Weg, E.; Rathkopf, D.; Morris, M. J.; Scher, H. I.; Kantoff, P. W.; Gopalan, A.; more...
    European Urology (2020)

    Fulltext@MSK | Save
  • First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: An open-label, single-arm, phase 2 trial
    Journal Article

    Janjigian, Y. Y.; Maron, S. B.; Chatila, W. K.; Millang, B.; Chavan, S. S.; Alterman, C.; Chou, J. F.; Segal, M. F.; Simmons, M. Z.; Momtaz, P.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • The role of cytoreductive nephrectomy for sarcomatoid renal cell carcinoma: A 29-year institutional experience
    Journal Article

    Silagy, A. W.; Mano, R.; Blum, K. A.; DiNatale, R. G.; Marcon, J.; Tickoo, S. K.; Reznik, E.; Coleman, J. A.; Russo, P.; Hakimi, A. A.
    Urology (2020)

    Fulltext@MSK | Save
  • Genomic differences between “primary” and “secondary” muscle-invasive bladder cancer as a basis for disparate outcomes to cisplatin-based neoadjuvant chemotherapy
    Editorial

    Pietzak, E. J.; Zabor, E. C.; Bagrodia, A.; Armenia, J.; Hu, W.; Zehir, A.; Funt, S.; Audenet, F.; Barron, D.; Maamouri, N.; more...
    European Urology (2019)

    Fulltext@MSK | Save
  • Next-generation sequencing of nonmuscle invasive bladder cancer reveals potential biomarkers and rational therapeutic targets
    Journal Article

    Pietzak, E. J.; Bagrodia, A.; Cha, E. K.; Drill, E. N.; Iyer, G.; Isharwal, S.; Ostrovnaya, I.; Baez, P.; Li, Q.; Berger, M. F.; more...
    European Urology (2017)

    Fulltext@MSK | Save
  • Redesigning the molecular pathology clinical report for the next-generation genomic era: The MSKCC experience with the MSK-IMPACT assay
    Meeting Abstract

    Syed, A.; Madur, S. H.; Birnbaum, J.; Balakrishnan, A. R.; Chakravarty, D.; Gao, J.; Zhang, H.; Phillips, S. M.; Schultz, N. D.; Rudolph, J.; more...
    Journal of Molecular Diagnostics (2017)

    Fulltext@MSK | Save